Low-dose tissue plasminogen activator in the management of anterior chamber fibrin formation

Journal of Cataract and Refractive Surgery

Volumn 29, Issue 4, 2003, Pages 729-732

  Georgiadis, Nick ^a   Boboridis, Kostas ^a,b   Halvatzis, Nick ^a   Ziakas, Nicolas ^a   Moschou, Vagia ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; STEROID;

ADULT; AGED; ANTERIOR EYE CHAMBER DISEASE; ARTICLE; CATARACT EXTRACTION; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EYE SURGERY; FEMALE; FIBRIN FORMATION; FIBRINOLYSIS; HUMAN; MALE; PENETRATING KERATOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0037386445     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0886-3350(02)01813-8     Document Type: Article

References (19)

1. Lundy DC, Sidoti P, Winarko T, et al. Intracameral tissue plasminogen activator after glaucoma surgery; indications, effectiveness, and complications. Ophthalmology 1996; 103:274-282
2. Starck T, Hopp L, Held KS, et al. Low-dose intraocular tissue plasminogen activator treatment for traumatic total hyphema, postcataract, and penetrating keratoplasty fibrinous membranes. J Cataract Refract Surg 1995; 21: 219-224
3. Williams GA, Lambrou FH, Jaffe GA, et al. Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator. Arch Ophthalmol 1988; 106:1055-1058
4. Wedrich A, Menapace R, Ries E, Polzer I. Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery. J Cataract Refract Surg 1997; 23:873-877
5. Giedrojc J, Stankiewicz A, Walkowiak M, et al. [Tissue plasminogen activator and plasminogen activator inhibitor in aqueous humor of the human eye]. [Polish] Klin Oczna 1996; 98:283-285
6. Moon J, Chung S, Myong Y, et al. Treatment of postcataract fibrinous membranes with tissue plasminogen activator. Ophthalmology 1992; 99:1256-1259
7. Chee CKL, Lim ASM. Severe fibrinous membrane formation after extracapsular cataract extraction. Implants Ophthalmol 1988; 2:140-147
8. Steinkamp GWK, Heider W, Schalnus R, Hattenbach L-O. Intraokulare rt-PA-Injektion bei Fibrinbildung nach kombinierter Glaukom- und Kataraktoperation. Ophthalmologe 1996; 93:558-560
9. Starck T. Treatment of fibrinous effusion [letter]. J Cataract Refract Surg 1998; 24:575
10. Lam DSC, Tham CCY, Leung ATS, Fan DSP. Managing postoperative pupillary membranes [letter]. J Cataract Refract Surg 1997; 23:972-973
11. Kotschy M, Kaluzny J, Kaniasty M, et al. [Tissue plasminogen activator (t-PA) in aqueous humor of patients with cataract]. [Polish] Klin Oczna 1996; 98:201-203
12. Löffler KU, Meyer JH, Wollensak G, Funk J. Erfolge und Komplikationen der rTPA-Behandlung am vordenen Augenbschnitt. Ophthalmologe 1997; 94:50-52
13. WuDunn D. Intracameral urokinase for dissolution of fibrin or blood clots after glaucoma surgery. Am J Ophthalmol 1997; 124:693-695
14. Kim M-H, Kao T-H, Sah W-J, Chung S-M. Treatment of total hyphema with relatively low-dose tissue plasminogen activator. Ophthalmic Surg Lasers 1998; 29:762-766
15. Althaus C, Schelle C, Sundmacher R. Akute bandförmige Keratopathie nach intraokularer Fibrinolyse mit rekombinantem Tissue-Plasminogen-Aktivator (rt-PA). Klin Monatsbl Augenheilkd 1996; 209:318-321
16. Ryan EH, Mizener JB. Tissue plasminogen activator and Staphylococcus epidermidis endophthalmitis. Arch Ophthalmol 1993; 111:1117-1122
17. Weiss JN. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol 1998; 126:142-144
18. Immonen I, Vaheri A, Tommila P, Sirén V. Plasminogen activation in epiretinal membranes. Graefes Arch Clin Exp Ophthalmol 1996; 234:664-669
19. Szymanski A, Gierek-Lapinska A, Koziak M, Gierek-Kalicka S. Corneal endothelial permeability in protection glaucoma filter bleb with tissue plasminogen activator. Int Ophthalmol 1995; 19:13-17